Anthony Evnin

Anthony Evnin, Ph.D., served as a Partner of Venrock, a venture capital firm, from 1975 to March 2021. Dr. Evnin currently serves on the Board of Directors of AVEO Pharmaceuticals and is on the Board of two private companies, Bridge Medicines, and Redpin Therapeutics. He is a Member of the Boards of Overseers and Managers of Memorial Sloan Kettering Cancer Center, a Trustee Emeritus of The Rockefeller University, a Trustee of The Jackson Laboratory, a Director of the New York Genome Center, a Member of the Board of Directors of the Albert and Mary Lasker Foundation, and a Trustee Emeritus of Princeton University. Dr. Evnin received an A.B. in chemistry from Princeton University and a Ph.D. in chemistry from the Massachusetts Institute of Technology.